ARCHIVES

Senate Commitee Approves $1.058 Trillion To Reverse Sequestration Cuts

This article is from The Cancer Letter archive.

Vol. 39 No. 25 | June 21, 2013

Download PDF Visit The Full Archive

Related Articles

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

Clinical Nutrition Academic Award Concept Approved

October 4, 1985

In Brief: Diagnostic Imaging Cost Declines By Half as Percentage Of Health Cost In 10 Years

January 11, 1985

Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now

December 2, 1983

NCI Approved Clinical Trials

May 28, 2010

NCI Advisory Group, Other Cancer Meetings for Oct., Nov., Future

September 29, 1989